Back

Anti-inflammatory treatment of COVID-19 patients: which drugs and which patients?

29 August 2021 (10:52 - 11:03)
Organised by:
Congress Presentation Part of: Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? Cardiovascular Disease in Specific Populations ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Anne Grete Semb

Diakonhjemmet Hospital, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Prevention of thromboembolism in COVID-19.
Professor A. Martinez-Rubio (Sabadell, ES)
Slides Video
Presentation thumbnail
COVID-19 myocarditis and myocardial injury: active participant or innocent bystander?
Professor G. Dan (Bucharest, RO)
Slides Video
Presentation thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion.
Presentation thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? - Chat Moderator.

Access the full session

Session thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 10:52 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources